Ad5.RSV-F

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAd5.RSV-F

Drug Alias Nameadenovirus serotype 5-based RSV vaccine (University of Pittsburg)

ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsRespiratory Syncytial Virus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Pittsburgh

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity Of Pittsburgh

Active IndicationsN/A

Inactive IndicationsRespiratory Syncytial Virus Infections

Other Information

ATC CodeN/A